ENVB
NASDAQ · Pharmaceuticals
Enveric Biosciences Inc
$1.42
+0.02 (+1.71%)
Open$1.39
Previous Close$1.40
Day High$1.46
Day Low$1.38
52W High$13.25
52W Low$1.17
Volume—
Avg Volume33.1K
Market Cap6.37M
P/E Ratio—
EPS$-11.15
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+595.9% upside
Current
$1.42
$1.42
Target
$9.91
$9.91
$5.56
$9.91 avg
$13.09
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 17.86B | 17.28B | 1.01M |
| Net Income | -117,299,047 | -102,147,210 | 237.2K |
| Profit Margin | -14.0% | -13.3% | 23.5% |
| EBITDA | -114,646,191 | -105,383,533 | 375.3K |
| Free Cash Flow | — | — | 127.9K |
| Rev Growth | +3.4% | +3.4% | -4.2% |
| Debt/Equity | — | — | 0.59 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |